|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Sales | |||
| Cost of sales | |||
| Gross profit | |||
| Operating costs: | |||
| Selling, general and administrative expenses | |||
| Research and development expenses | |||
| Operating profit | |||
| Nonoperating income (expense): | |||
| Other income (expense), net | |||
| Interest expense, net | |||
| Earnings before income taxes | |||
| Income taxes | |||
| Net earnings | |||
| Net earnings per common share: | |||
| Basic (in usd per share) | |||
| Diluted (in usd per share) | |||
| Average common stock and common equivalent shares outstanding: | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...
